Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements.
Kimmerling RJ, Stevens MM, Olcum S, Minnah A, Vacha M, LaBella R, Ferri M, Wasserman SC, Fujii J, Shaheen Z, Sundaresan S, Ribadeneyra D, Jayabalan DS, Agte S, Aleman A, Criscitiello JA, Niesvizky R, Luskin MR, Parekh S, Rosenbaum CA, Tamrazi A, Reid CA. Kimmerling RJ, et al. Among authors: rosenbaum ca. Commun Biol. 2022 Nov 26;5(1):1295. doi: 10.1038/s42003-022-04270-3. Commun Biol. 2022. PMID: 36435843 Free PMC article.
Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements.
Kimmerling RJ, Stevens MM, Olcum S, Minnah A, Vacha M, LaBella R, Ferri M, Wasserman SC, Fujii J, Shaheen Z, Sundaresan S, Ribadeneyra D, Jayabalan DS, Agte S, Aleman A, Criscitiello JA, Niesvizky R, Luskin MR, Parekh S, Rosenbaum CA, Tamrazi A, Reid CA. Kimmerling RJ, et al. Among authors: rosenbaum ca. Commun Biol. 2023 Jan 6;6(1):15. doi: 10.1038/s42003-022-04376-8. Commun Biol. 2023. PMID: 36609595 Free PMC article. No abstract available.
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies.
Stevens MM, Kimmerling RJ, Olcum S, Vacha M, LaBella R, Minnah A, Katsis K, Fujii J, Shaheen Z, Sundaresan S, Criscitiello J, Niesvizky R, Raje N, Branagan A, Krishnan A, Jagannath S, Parekh S, Sperling AS, Rosenbaum CA, Munshi N, Luskin MR, Tamrazi A, Reid CA. Stevens MM, et al. JCO Precis Oncol. 2024 Jan;8:e2300349. doi: 10.1200/PO.23.00349. JCO Precis Oncol. 2024. PMID: 38237098 Free PMC article.
Absolute Lymphocyte Count after BCMA CAR-T Therapy is a Predictor of Response and Outcomes in Relapsed Multiple Myeloma.
Mejia Saldarriaga M, Pan D, Unkenholz C, Mouhieddine TH, Velez-Hernandez JE, Engles K, Fein JA, Monge J, Rosenbaum CA, Pearse R, Jayabalan DS, Gordillo CA, Chan HT, Yamshon S, Thibaud S, Mapara MY, Inghirami GG, Lentzsch S, Reshef R, Rossi A, Parekh S, Jagannath S, Richard S, Niesvizky R, Bustoros M. Mejia Saldarriaga M, et al. Among authors: rosenbaum ca. Blood Adv. 2024 May 22:bloodadvances.2023012470. doi: 10.1182/bloodadvances.2023012470. Online ahead of print. Blood Adv. 2024. PMID: 38776397
Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain Amyloidosis.
Gertz M, Abonour R, Gibbs SN, Finkel M, Landau H, Lentzsch S, Lin G, Mahindra A, Quock T, Rosenbaum C, Rosenzweig M, Sidana S, Tuchman SA, Witteles R, Yermilov I, Broder MS. Gertz M, et al. Among authors: rosenbaum c. Clinicoecon Outcomes Res. 2023 Sep 11;15:673-680. doi: 10.2147/CEOR.S412079. eCollection 2023. Clinicoecon Outcomes Res. 2023. PMID: 37719133 Free PMC article.
[Urethral reconstruction].
Rosenbaum CM, Netsch C, Gross AJ, Becker B. Rosenbaum CM, et al. Urologie. 2024 Jun 4. doi: 10.1007/s00120-024-02369-5. Online ahead of print. Urologie. 2024. PMID: 38833015 German.
[Hydrocele].
Filmar S, Gross AJ, Hook S, Rosenbaum CM, Netsch C, Becker B. Filmar S, et al. Among authors: rosenbaum cm. Urologie. 2024 Jun;63(6):607-617. doi: 10.1007/s00120-024-02367-7. Epub 2024 May 23. Urologie. 2024. PMID: 38780784 Review. German.
Prolongation of the gastric residence time of caffeine after administration in fed state: Comparison of effervescent granules with an extended release tablet.
Foja C, Senekowitsch S, Winter F, Grimm M, Rosenbaum C, Koziolek M, Feldmüller M, Kromrey ML, Scheuch E, Tzvetkov MV, Weitschies W, Schick P. Foja C, et al. Among authors: rosenbaum c. Eur J Pharm Biopharm. 2024 Jun;199:114313. doi: 10.1016/j.ejpb.2024.114313. Epub 2024 May 7. Eur J Pharm Biopharm. 2024. PMID: 38718842 Free article.
245 results